COCONUT CREEK, Fla.--(BUSINESS WIRE)--InnoMed Technologies Inc., a medical equipment manufacturer of respiratory and sleep interface products for use in hospitals, institutions and homecare settings, announced that DeVilbiss Healthcare is no longer the exclusive distributor of InnoMed Technologies products. “With competitive bidding and declining reimbursement rates, demands are being placed on manufacturers to reduce prices and in order to remain competitive with companies such as ResMed (RMD:NYSE), Fisher & Paykel Healthcare Corporation Limited (FPH:ENZL), and Phillips Respironics (PHG:NYSE), we believe moving towards a direct sales model is the right thing to do. DeVilbiss was a good partner for many years, but with the recent changes in the health care environment, InnoMed has to plan for the future and create a solid business model for our customers and investors,” states Ron Richard, CEO of InnoMed Technologies.
InnoMed Technologies will remain dedicated to developing innovative sleep and respiratory products while putting a greater emphasis on their direct relationship with its customers. Bringing the sales efforts in house will broaden the reach of their product mix and a renewed focus on customer care and educational support for patients and clinicians will facilitate continued breakthroughs in interface technologies.
“We have been in close contact with the senior staff at DeVilbiss to ensure a smooth transition occurs and patients are not without the products they depend on for their treatment of sleep disorders,” continues Richard. “The transition begins August 12th and over the next few weeks we will be contacting providers to insure they have the right information to place orders directly with InnoMed Technologies.”
InnoMed Technologies Inc., whose flagship product line the Nasal-Aire® nasal interface debuted in 2001, has continued to innovate ground breaking products along with its sister company RespCare, whose products are now distributed solely by InnoMed Technologies. Products such as the Hybrid® oral nasal interface and, more recently, the Aloha® nasal pillow interface have kept the company a cutting edge force in the sleep industry. InnoMed looks forward to what is sure to be an exciting and prosperous year.
About InnoMed Technologies, Inc.
InnoMed Technologies, Inc. (www.innomedinc.com) is a research-oriented, privately held company that manufactures and markets innovative medical devices to treat obstructive sleep apnea and respiratory insufficiency. InnoMed Technologies, Inc. holds numerous patents with numerous patents pending.
InnoMed Technologies Inc. manages and distributes a highly acclaimed line of respiratory and sleep devices, including Nasal-Aire®, Hybrid®, Aloha®, Sylent®, Bravo® and Utopia® line of interfaces.
About Mergenet Medical Inc. (MMI): Mergenet Medical Inc. (sister company of InnoMed Technologies) whose highly anticipated High Flow Therapy System expected to launch internationally in 2014 is a global medical device company that designs and manufactures innovative medical devices that assist healthcare institutions measurably improve outcomes, reduce infections and improve patient and provider safety. Learn more at www.mergenetmedical.com.
